GINKGO BIOWORKS HOLDINGS, INC. Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted of -$80.75 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Income Statement › Other Income
us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted · last filed 2025-11-06
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-09-30 was -$80.75M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-06-30 was -$60.30M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2025-03-31 was -$90.96M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for the quarter ending 2024-12-31 was -$107.20M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2024 was -$547.03M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2023 was -$892.87M.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2022 was -$2.11B.
- GINKGO BIOWORKS HOLDINGS, INC. net income (loss) from continuing operations available to common shareholders, diluted for fiscal 2021 was -$1.89B.
| Period end | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 3 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 6 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 9 month | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$80.75M 10-Q · filed 2025-11-06 | -$141.06M derived: sum of 2 quarters · filed 2025-11-06 | -$232.01M 10-Q · filed 2025-11-06 | -$339.21M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | -$60.30M 10-Q · filed 2025-08-07 | -$151.26M 10-Q · filed 2025-08-07 | -$258.46M derived: sum of 3 quarters · filed 2025-08-07 | -$314.89M derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-03-31 | -$90.96M 10-Q · filed 2025-05-06 | -$198.16M derived: sum of 2 quarters · filed 2025-05-06 | -$254.59M derived: sum of 3 quarters · filed 2025-11-06 | -$471.96M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-12-31 | -$107.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$163.63M derived: sum of 2 quarters · filed 2025-11-06 | -$381.00M derived: sum of 3 quarters · filed 2025-11-06 | -$547.03M 10-K · filed 2025-02-25 |
| 2024-09-30 | -$56.43M 10-Q · filed 2025-11-06 | -$273.80M derived: sum of 2 quarters · filed 2025-11-06 | -$439.83M 10-Q · filed 2025-11-06 | -$651.87M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$217.37M 10-Q · filed 2025-08-07 | -$383.39M 10-Q · filed 2025-08-07 | -$595.43M derived: sum of 3 quarters · filed 2025-08-07 | -$898.33M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$166.38M 10-Q · filed 2025-05-06 | -$378.07M derived: sum of 2 quarters · filed 2025-05-06 | -$680.96M derived: sum of 3 quarters · filed 2025-05-06 | -$854.27M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | -$211.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$514.59M derived: sum of 2 quarters · filed 2025-02-25 | -$687.90M derived: sum of 3 quarters · filed 2025-02-25 | -$892.87M 10-K · filed 2025-02-25 |
| 2023-09-30 | -$302.89M 10-Q · filed 2024-11-12 | -$476.21M derived: sum of 2 quarters · filed 2024-11-12 | -$681.17M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$173.31M 10-Q · filed 2024-08-08 | -$378.28M 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$205.58M 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$2.11B 10-K · filed 2025-02-25 | |||
| 2022-03-31 | -$590.50M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | -$1.89B 10-K · filed 2024-02-29 | |||
| 2020-12-31 | -$126.61M 10-K · filed 2023-03-13 | |||
| 2019-12-31 | -$119.33M 10-K · filed 2022-03-29 |